Clinical implications of stopping nevirapine-based antiretroviral therapy: relative pharmacokinetics and avoidance of drug resistance
- 1 May 2004
- journal article
- case report
- Published by Wiley in HIV Medicine
- Vol. 5 (3), 180-184
- https://doi.org/10.1111/j.1468-1293.2004.00208.x
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Virological and immunological effects of short-course antiretroviral therapy in primary HIV infectionAIDS, 2002
- Development of Resistance Mutations in Women Receiving Standard Antiretroviral Therapy Who Received Intrapartum Nevirapine to Prevent Perinatal Human Immunodeficiency Virus Type 1 Transmission: A Substudy of Pediatric AIDS Clinical Trials Group Protocol 316The Journal of Infectious Diseases, 2002
- Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)AIDS, 2001
- Changes in Human Immunodeficiency Virus Type 1 Populations after Treatment Interruption in Patients Failing Antiretroviral TherapyJournal of Virology, 2001
- High‐Dose Nevirapine in Previously Untreated Human Immunodeficiency Virus Type 1‐Infected Persons Does Not Result in Sustained Suppression of Viral ReplicationThe Journal of Infectious Diseases, 1997